2018

 

06_Pieris
September 4, 2018
Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I
Combination Trial for PRS-343 Plus Anti-PD-L1 Immunotherapy

 

ers
July 11, 2018
ERS Electronic is Announcing Woowon Technology Co., Ltd. as New Sales Channel Partner

 

lophius
May 15, 2018
Biomax Informatics Software Licensed by Royal DSM

 

03_Memo
May 9, 2018
Memo Therapeutics AG Closes Series A2 Financing Round of CHF 5 Million

 

lophius
April 10, 2018
Biomax Informatics Software Licensed by Global Pharma Company,
Boehringer Ingelheim

 
sobera_News
April 3, 2018
Sobera Capital Exits AMICRA to ASM Pacific Technologies

 

amicra
April 3, 2018
ASM Pacific Technology Acquires Amicra to Enter the Photonics Market

 

ers
March 13, 2018
ERS Electronic Announces That its Industry-Leading AirCool® PRIME Thermal Chuck technology Will Soon be Available For 200 mm Wafer Testing

 

sobera_News
February 26, 2018
Sobera Capital Acquires International Portfolio of Direct Interests from Innoveas

 

06_Pieris
February 16, 2018
Pieris Pharmaceuticals Announces Closing of Public Offering and Exercise of Underwriters' Option to Purchase Additional Shares

 

06_Pieris
February 09, 2018
Pieris Pharmaceuticals and Seattle Genetics Announce Multi-Program Immuno-Oncology Collaboration

 

lophius
February 08, 2018
T-Track® CMV is a Highly Sensitive Immune-Monitoring Tool for Risk Stratification of Renal Transplant Recipients

 

05_Paratek
February 05, 2018
Paratek Completes Submission of New Drug Applications to U.S. Food and Drug Administration for Oral and Intravenous Omadacycline for Pneumonia and Skin Infections

 

05_Paratek
January 18, 2018
Paratek Announces Pricing of Public Offering of Common Stock